UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

BMC neurology, 2021-03, Vol.21 (1), p.126-126, Article 126

2021

Volltextzugriff (PDF)

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

The Journal of pharmacology and experimental therapeutics, 2019-04, Vol.369 (1), p.26-36

2019

Volltextzugriff (PDF)

Red Flags and Comfort Signs for Ominous Secondary Headaches

Otolaryngologic clinics of North America, 2014-04, Vol.47 (2), p.289-299

Cady, Roger K., MD

2014

Volltextzugriff (PDF)

Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

Headache, 2006-01, Vol.46 (1), p.24-33

2006

Volltextzugriff (PDF)

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study

Neurology, 2016-08, Vol.87 (5), p.529-538

2016

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Journal of the neurological sciences, 2013-08, Vol.331 (1), p.48-56

2013

Volltextzugriff (PDF)

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Headache, 2008-07, Vol.48 (7), p.1012-1025

2008

Volltextzugriff (PDF)

Long-Term Efficacy of a Double-Blind, Placebo-Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360® Device for Treatment of Chronic Migraine

Headache, 2015-04, Vol.55 (4), p.529-542

2015

Volltextzugriff (PDF)

The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine

Headache, 2007-11, Vol.47 (10), p.1398-1408

2007

Volltextzugriff (PDF)

Acupuncture in the Treatment of Headache: A Traditional Explanation of an Ancient Art

Headache, 2015-03, Vol.55 (3), p.457-464

2015

Volltextzugriff (PDF)

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

Journal of headache and pain, 2017-12, Vol.18 (1), p.17-8, Article 17

2017

Volltextzugriff (PDF)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Volltextzugriff (PDF)

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Headache, 2015-05, Vol.55 (5), p.621-635

2015

Volltextzugriff (PDF)

Chronic migraine in women

The Journal of family practice, 2014-02, Vol.63 (2 Suppl), p.S46-S51

Cady, Roger K

2014

Volltextzugriff (PDF)

Managing migraine by patient profile: role of frovatriptan

Patient preference and adherence, 2016-01, Vol.10, p.501-510

2016

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Headache, 2015-01, Vol.55 (1), p.88-100

2015

Volltextzugriff (PDF)

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan

Headache, 2009-10, Vol.49 (9), p.1258-1266

2009

Volltextzugriff (PDF)

Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg

Clinical therapeutics, 2007, Vol.29 (11), p.2511-2519

2007

Volltextzugriff (PDF)

A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine

Headache, 2011-01, Vol.51 (1), p.21-32

2011

Volltextzugriff (PDF)

Advances in Drug Development for Acute Migraine

Drugs (New York, N.Y.), 2012-12, Vol.72 (17), p.2187-2205

2012

Volltextzugriff (PDF)

The Convergence Hypothesis

Headache, 2007-04, Vol.47 (s1), p.S44-S51

Cady, Roger K.

2007

Volltextzugriff (PDF)

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Journal of headache and pain, 2017-12, Vol.18 (1), p.31-8, Article 31

2017

Volltextzugriff (PDF)

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesicTMM) in the Treatment of Migraine

Headache, 2011-07, Vol.51 (7), p.1078-1086

2011

Volltextzugriff (PDF)

The Bowel and Migraine: Update on Celiac Disease and Irritable Bowel Syndrome

Current pain and headache reports, 2012-06, Vol.16 (3), p.278-286

2012

Volltextzugriff (PDF)

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

Headache, 2008-10, Vol.48 (9), p.1326-1336

2008

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Publikationsformmagazinearticle

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(126)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Humans
(91)
Life Sciences & Biomedicine
(91)
Migraine
(64)
Migraine Disorders - Drug Therapy
(64)
Female
(61)
Adult
(59)
Neurosciences & Neurology
(56)
Clinical Neurology
(55)
Male
(53)
Biological And Medical Sciences
(52)
Medical Sciences
(50)
Neurology
(44)
Middle Aged
(43)
Pharmacology. Drug Treatments
(38)
Vascular Diseases And Vascular Malformations Of The Nervous System
(38)
Double-Blind Method
(32)
Cardiovascular System
(30)
Vasodilator Agents. Cerebral Vasodilators
(30)
Treatment Outcome
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

Red Flags and Comfort Signs for Ominous Secondary Headaches

Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Long-Term Efficacy of a Double-Blind, Placebo-Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360® Device for Treatment of Chronic Migraine

The Impact of Topiramate on Health-Related Quality of Life Indicators in Chronic Migraine

Acupuncture in the Treatment of Headache: A Traditional Explanation of an Ancient Art

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine

AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

AVP-825 Breath-Powered Intranasal Delivery System Containing 22mg Sumatriptan Powder vs 100mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks

Chronic migraine in women

Managing migraine by patient profile: role of frovatriptan

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan

Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg

A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine

Advances in Drug Development for Acute Migraine

The Convergence Hypothesis

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

A Double-Blind Placebo-Controlled Pilot Study of Sublingual Feverfew and Ginger (LipiGesicTMM) in the Treatment of Migraine

The Bowel and Migraine: Update on Celiac Disease and Irritable Bowel Syndrome

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

Aktive Filter

Suchergebnisse filtern